Marina Cella

Marina Cella

Auto-generated profile, based on publicly available information

Marina Cella

Department of Pathology and Immunology, Washington University School of Medicine in St. Louis, St. Louis, MO, USA

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 1995 in Journal of Experimental Medicine
Verified
Journal Article
Open access
FSF Sallusto
F Sallusto
MCM Cella
M Cella
CDC Danieli
C Danieli
ALA Lanzavecchia
A Lanzavecchia
We have previously demonstrated that human peripheral blood low density mononuclear cells cultured in granulocyte/macrophage colony-stimulating factor (GM-CSF) and interleukin (IL)-4 develop into dendritic cells (DCs) that are extremely efficient in presenting soluble antigens to T cells. To identify the mechanisms responsible for efficient antigen capture, we studied the endocytic capacity of DCs using fluorescein isothiocyanate-dextran, horseradish peroxidase, and lucifer yellow. We found that DCs use two distinct mechanisms for antigen capture. The first is a high level of fluid phase uptake via macropinocytosis. In contrast to what has been found with other cell types, macropinocytosis in DCs is constitutive and allows continuous internalization of large volumes of fluid. The second mechanism of capture is mediated via the mannose receptor (MR), which is expressed at high levels on DCs. At low ligand concentrations, the MR can deliver a large number of ligands to the cell in successive rounds. Thus, while macropinocytosis endows DCs with a high capacity, nonsaturable mechanism for capture of any soluble antigen, the MR gives an extra capacity for antigen capture with some degree of selectivity for non-self molecules. In addition to their high endocytic capacity, DCs from GM-CSF + IL-4-dependent cultures are characterized by the presence of a large intracellular compartment that contains high levels of class II molecules, cathepsin D, and lysosomal-associated membrane protein-1, and is rapidly accessible to endocytic markers. We investigated whether the capacity of DCs to capture and process antigen could be modulated by exogenous stimuli. We found that DCs respond to tumor necrosis factor alpha, CD40 ligand, IL-1, and lipopolysaccharide with a coordinate series of changes that include downregulation of macropinocytosis and Fc receptors, disappearance of the class II compartment, and upregulation of adhesion and costimulatory molecules. These changes occur within 1-2 d and are irreversible, since neither pinocytosis nor the class II compartment are recovered when the maturation-inducing stimulus is removed. The specificity of the MR and the capacity to respond to inflammatory stimuli maximize the capacity of DCs to present infectious non-self antigens to T cells.

1 March 2015 in Cell
Verified
Journal Article
Closed access
YWYaming Wang
Yaming Wang
MCMarina Cella
Marina Cella
KMKaitlin Mallinson
Kaitlin Mallinson
JUJason D. Ulrich
Jason D. Ulrich
KYKatherine L. Young
Katherine L. Young
MCMarco Colonna
Marco Colonna

1 August 1996 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
MCM Cella
M Cella
DSD Scheidegger
D Scheidegger
KPK Palmer-Lehmann
K Palmer-Lehmann
PLP Lane
P Lane
ALA Lanzavecchia
A Lanzavecchia
GAG Alber
G Alber
We investigated the possibility that T helper cells might enhance the stimulatory function of dendritic cells (DCs). We found that ligation of CD40 by CD40L triggers the production of extremely high levels of bioactive IL-12. Other stimuli such as microbial agents, TNF-alpha or LPS are much less effective or not at all. In addition, CD40L is the most potent stimulus in upregulating the expression of ICAM-1, CD80, and CD86 molecules on DCs. These effects of CD40 ligation result in an increased capacity of DCs to trigger proliferative responses and IFN-gamma production by T cells. These findings reveal a new role for CD40-CD40L interaction in regulating DC function and are relevant to design therapeutic strategies using cultured DCs.

1 August 1999 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
MCMarina Cella
Marina Cella
DJDavid Jarrossay
David Jarrossay
FFFabio Facchetti
Fabio Facchetti
OAOlga Alebardi
Olga Alebardi
HNHideo Nakajima
Hideo Nakajima
MCMarco Colonna
Marco Colonna

1 August 2017 in Cell
Verified
Journal Article
Closed access
TUTyler Ulland
Tyler Ulland
WSWilbur M. Song
Wilbur M. Song
SHStanley Ching-Cheng Huang
Stanley Ching-Cheng Huang
JUJason D. Ulrich
Jason D. Ulrich
ASAlexey Sergushichev
Alexey Sergushichev
MCMarco Colonna
Marco Colonna

2 November 2008 in Nature
Verified
Journal Article
Closed access
PDF file
MCMarina Cella
Marina Cella
AFAnja Fuchs
Anja Fuchs
WVWilliam Vermi
William Vermi
FFFabio Facchetti
Fabio Facchetti
KOKarel Otero
Karel Otero
MCMarco Colonna
Marco Colonna